Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

Y0001130

Cimetidine for peak identification

European Pharmacopoeia (EP) Reference Standard

Sinonimo/i:

Cimetidine, SKF-92334

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C10H16N6S
Numero CAS:
51481-61-9
Peso molecolare:
252.34
Numero MDL:
MFCD00133296
Codice UNSPSC:
41116107
ID PubChem:
329831280
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

cimetidine

Produttore/marchio commerciale

EDQM

applicazioni

pharmaceutical (small molecule)

Formato

neat

Temperatura di conservazione

2-8°C

Stringa SMILE

CN\C(NC#N)=N\CCSCc1nc[nH]c1C

InChI

1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)
AQIXAKUUQRKLND-UHFFFAOYSA-N

Informazioni sul gene

human ... HRH2(3274)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Cimetidine for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

PHR1075

Cimetidine, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1089

Cimetidine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

1134073

Cimetidine hydrochloride, United States Pharmacopeia (USP) Reference Standard

C2175500

Cimetidine hydrochloride, European Pharmacopoeia (EP) Reference Standard

C2175000

Cimetidine, European Pharmacopoeia (EP) Reference Standard

Y0001146

Cimetidine for system suitability, European Pharmacopoeia (EP) Reference Standard

1134062

Cimetidine, United States Pharmacopeia (USP) Reference Standard

BP475

Cimetidine, British Pharmacopoeia (BP) Reference Standard

PHR2242

Cimetidine Impurity D, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2220

Cimetidine Impurity A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2250

Cimetidine Impurity B, pharmaceutical secondary standard, certified reference material

PHR2251

Cimetidine Impurity C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2252

Cimetidine Impurity J, certified reference material, pharmaceutical secondary standard

PHR2259

Cimetidine Impurity G, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2260

Cimetidine Impurity I, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2255

Cimetidine Impurity H

PHR2243

Cimetidine Impurity E, Pharmaceutical Secondary Standard; Certified Reference Material

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Martina Kubecova et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 42(5), 439-444 (2011-02-19)
Cimetidine, H(2) receptor antagonists, is commonly prescribed for gastric and duodenal ulcer disease. Additionally, cimetidine has been shown to have anticancer effects. This review describes the mechanism of antitumor action of cimetidine including its ability to interfere with tumor cell
Florence Lefranc et al.
International journal of oncology, 28(5), 1021-1030 (2006-04-06)
Cimetidine (CIM), the prototypical histamine H2 receptor antagonist (H2RA), was brought to market based on its ability to accelerate healing of gastrointestinal ulcers through the inhibition of gastric acid secretion. Cimetidine, the most studied H2RA, has been demonstrated to possess
J E Naschitz et al.
Seminars in arthritis and rheumatism, 21(4), 211-220 (1992-02-01)
The term fasciitis-panniculitis syndrome (FPS) is proposed as a novel compilation encompassing several disorders, common to which is subcutaneous induration caused by cicatrizing fasciitis as well as septal and lobular panniculitis and perimysial fibrosis. Included herein are Shulman's eosinophilic fasciitis
P San Miguel et al.
Virchows Archiv : an international journal of pathology, 430(3), 261-263 (1997-03-01)
A case of carcinoma in the breast of a male patient with a chronic gastric ulcer is described. The patient had received cimetidine for 17 years. Histological examination of an excisional biopsy showed lobular in situ and infiltrating carcinoma. In
J P Harcourt et al.
International journal of pediatric otorhinolaryngology, 51(2), 109-113 (2000-01-05)
Effective adjuvant treatment for recurrent respiratory papillomatosis (RRP) is at present limited to alpha-interferon, which may have significant side effects including rebound growth of papillomata following its withdrawal, is given by injection and is expensive. High dose cimetidine is known
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.